Biogen Idec

Biogen Idec Dominant Player In Multiple Sclerosis Market
investors.com
Sat, 10/12/13 - 11:55 am
Biogen Idec
MS
multiple sclerosis
7 Disruptive Drugs for the Next Decade
Motley Fool
Wed, 10/9/13 - 10:42 pm
Tecfidera
Biogen Idec
Bristol-Myers Squibb
Eliquis
Pfizer
Roche
Kadcyla
Immunogen
sofosbuvir
Gilead
ibrutinib
Pharmacyclics
Sarepta
eteplirsen
LX4211
Lexicon Pharmaceuticals
Experts thinks Biogen to likely be able to market Tecfidera in EU, says Leerink
Yahoo/Fly on the Wall
Mon, 10/7/13 - 11:01 am
Biogen Idec
multiple sclerosis
MS
Europe
Tecfidera
Is This Biotech Cornering the Market for MS Treatments?
Motley Fool
Sat, 10/5/13 - 09:52 am
Biogen Idec
MS
multiple sclerosis
Biogen's new MS drug maintains efficacy long term -study
Yahoo/Reuters
Fri, 10/4/13 - 10:18 am
MS
multiple sclerosis
Biogen Idec
Tecfidera
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Biogen, Isis Pharma And The Attraction Of The Orphan Drug Business
Seeking Alpha
Mon, 09/30/13 - 10:38 am
Biogen Idec
Isis Pharmaceuticals
orphan drugs
Kynamro
ISIS-DMPKRx
3 Signs We Could Be Entering a Biotech Bubble
Motley Fool
Sat, 09/28/13 - 01:09 pm
biotech
Perrigo
Bristol-Myers Squibb
Elan
Clovis Oncology
IPOs
Stemline
Amgen
Biogen Idec
ONYX Pharmaceuticals
Insiders Are Selling Biogen Idec
Seeking Alpha
Tue, 09/24/13 - 05:57 pm
Biogen Idec
AbbVie
Amgen
Bristol-Myers Squibb
JNJ
Merck
Pfizer
Cephalon
Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas
Yahoo/Wall St 24-7
Mon, 09/16/13 - 10:09 am
biotech
Th2 immune pathway
MS
multiple sclerosis
Biogen Idec
Regeneron
Sanofi
GSK
3 Key Takeaways From Isis' Investor Roadshow Week
Motley Fool
Fri, 09/13/13 - 03:50 pm
Isis Pharmaceuticals
ISIS-APOCIIIRx
Biogen Idec
Biogen Tops 4 Big Biotechs For A Healthy Portfolio
Investors.com
Wed, 09/11/13 - 08:52 am
Biogen Idec
Celgene
Alexion
Regeneron
Busy Biogen Idec fuels Amicus in Parkinson's drug chase
Fierce Biotech
Tue, 09/10/13 - 11:28 am
Biogen Idec
Amicus
Parkinson's Disease
Biogen Expands Isis Partnership in $100 Million Drug Deal
Bloomberg
Mon, 09/9/13 - 09:46 am
Biogen Idec
Isis Pharmaceuticals
R&D
Biogen may be capturing 50% of new MS patients, says Cowen
Yahoo/Fly on the Wall
Fri, 09/6/13 - 08:58 am
MS
Biogen Idec
multiple sclerosis
Tecfidera
Biogen Multiple Sclerosis Drug May Become Blockbuster
investors.com
Sat, 08/24/13 - 11:38 am
Biogen Idec
MS
multiple sclerosis
Tecfidera
Multiple Sclerosis market to reach more than $18bn by 2018
Datamonitor Healthcare
Tue, 08/20/13 - 12:13 pm
MS
multiple sclerosis
Biogen Idec
Tecfidera
6 Oncology-Focused Biotech Growth Engines
Seeking Alpha
Sat, 08/3/13 - 10:33 am
Celgene
Regeneron
Biogen Idec
Gilead Sciences
ONYX Pharmaceuticals
Celldex
Biogen Idec Product Pipeline Will Propel It Higher
Seeking Alpha
Sat, 08/3/13 - 10:26 am
Biogen Idec
Zacks Industry Outlook Highlights: Johnson & Johnson, Forest Labs, Biogen, Amgen and Medivation
Yahoo/Zacks
Wed, 07/31/13 - 09:17 am
JNJ
Forest Labs
Biogen Idec
Amgen
Medivation

Pages